NPTN Mouse Monoclonal Antibody [Clone ID: OTI2F5]

CAT#: CF504452

Carrier-free (BSA/glycerol-free) NPTN mouse monoclonal antibody, clone OTI2F5 (formerly 2F5)

Formulation: Standard Carrier-Free



  View other "OTI2F5" antibodies (4)

Need it in bulk or conjugated?
Get a free quote

CNY 3,999.00


货期*
2周

规格
    • 100 ug

Product images

经常一起买 (2)
Biotinylation Labelling Kit formatted 4 x 0.05mg
    • 200 ug

CNY 3,170.00


HRP Conjugation kit for 0.2mg IgG
    • 200 ug

CNY 3,230.00

Specifications

Product Data
Clone Name OTI2F5
Applications IF, WB
Recommend Dilution WB 1:2000, IF 1:100
Reactivity Human, Rat
Host Mouse
Clonality Monoclonal
Immunogen Full length human recombinant protein of human NPTN(NP_059429) produced in HEK293T cell.
Formulation Lyophilized powder (original buffer 1X PBS, pH 7.3, 8% trehalose)
Reconstitution Method For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process. (OriGene recommends Zeba Spin Desalting Columns, 7KMWCO from Thermo Scientific)
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Predicted Protein Size 28.7 kDa
Gene Name neuroplastin
Background This gene encodes a type I transmembrane protein belonging to the Ig superfamily. The protein is believed to be involved in cell-cell interactions or cell-substrate interactions. Alternative splicing results in multiple transcript variants. [provided by RefSeq]
Synonyms GP55; GP65; np55; np65; SDFR1; SDR1
Reference Data
Protein Families Druggable Genome, Transmembrane
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...